Afatinib Dimaleate received regulatory approval for use as a treatment for non-small cell lung cancer, although there is emerging evidence to support its use in other cancers such as breast cancer. Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma. Reference standards of Afatinib Dimaleate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Afatinib Dimaleate
Catalogue No.:PA 28 40000
CAS :
Molecular Formula : C32H33ClFN5O11
Molecular Weight : 718.09
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....